Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Difference, Individual
- Sponsor
- Erasme University Hospital
- Enrollment
- 4000
- Locations
- 1
- Primary Endpoint
- Difference of timing for Electrochemical skin conductance
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers
Detailed Description
Objective: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers Background: Sudoscan is a tool developed to evaluate and screen peripheral neuropathies in diabetes. His indication has been extended to other neuropathies such as post-chemotherapy, Fabry's disease, Parkinson's disease, familial amyloid polyneuropathy. Main objective: Evaluation of the relevance of cutaneous electrochemical conductance in chronic peripheral neuropathies. Methodology : Recruitment of 2 groups of 2000 patients Group 1: Patients with chronic neuropathy, during clinic bread consultation Group 2: Patients to benefit from scheduled surgery seen during anesthesia consultation For both groups filling the central awareness inventory questionnaire Analysis of the results after the recruitment has been completed.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients group : Not have a chronic neuropathy
Outcomes
Primary Outcomes
Difference of timing for Electrochemical skin conductance
Time Frame: 3 minutes
the investigators will measure the timing between the 4 members for the Electrochemical skin conductance